These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18035130)

  • 1. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.
    Schleiss MR
    J Pediatr; 2007 Dec; 151(6):564-70. PubMed ID: 18035130
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in cytomegalovirus vaccine development.
    Schleiss M
    Herpes; 2005 Dec; 12(3):66-75. PubMed ID: 16393522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CMV vaccine trials: what if CMV caused a rash?
    Adler SP
    J Clin Virol; 2008 Mar; 41(3):231-6. PubMed ID: 18096431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
    Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R;
    Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
    Schleiss MR
    J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prospects for immunization against cytomegaloviral disease.
    Adler SP
    Infect Agents Dis; 1996 Jan; 5(1):29-35. PubMed ID: 8789597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization strategy for prevention of congenital cytomegalovirus infection.
    Pass RF
    Infect Agents Dis; 1996 Oct; 5(4):240-4. PubMed ID: 8884369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward an elusive goal: current status of cytomegalovirus vaccines.
    Schleiss MR; Heineman TC
    Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.
    Pass RF; Burke RL
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):196-204. PubMed ID: 12199616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization to prevent congenital cytomegalovirus infection.
    Adler SP
    Br Med Bull; 2013; 107():57-68. PubMed ID: 23954939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of congenital CMV infection].
    Nozawa N; Inoue N
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():446-50. PubMed ID: 16615512
    [No Abstract]   [Full Text] [Related]  

  • 13. [Congenital cytomegalovirus infection].
    de Bel CE; de Groot R; Schrander JJ; Rothbarth PH
    Tijdschr Kindergeneeskd; 1990 Dec; 58(6):211-7. PubMed ID: 1965237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beginning of the end of a long wait for a vaccine against cytomegalovirus.
    Griffiths P
    Rev Med Virol; 2009 May; 19(3):117-9. PubMed ID: 19388047
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus.
    Dempsey AF; Pangborn HM; Prosser LA
    Vaccine; 2012 Jun; 30(27):4060-6. PubMed ID: 22525796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling immunization strategies with cytomegalovirus vaccine candidates.
    Azevedo RS; Amaku M
    Epidemiol Infect; 2011 Dec; 139(12):1818-26. PubMed ID: 21396147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus vaccines: current status.
    Starr SE
    Infect Agents Dis; 1992 Jun; 1(3):146-8. PubMed ID: 1365538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The March towards a Vaccine for Congenital CMV: Rationale and Models.
    Bialas KM; Permar SR
    PLoS Pathog; 2016 Feb; 12(2):e1005355. PubMed ID: 26866914
    [No Abstract]   [Full Text] [Related]  

  • 19. One step closer to a CMV vaccine.
    Dekker CL; Arvin AM
    N Engl J Med; 2009 Mar; 360(12):1250-2. PubMed ID: 19297578
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine strategies against human cytomegalovirus infection.
    Zhong J; Khanna R
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.